CClinicalTrials.gg
CompletedNCT00403312Updated Jul 2, 2008

Increasing Physical Activity as Part of a Smoking Cessation Program

An interventional study of Smoking Cessation Behavioral Program and Nicotine Patch in Smoking Cessation, sponsored by National Heart, Lung, and Blood Institute (NHLBI). Completed at 2 sites in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-07-02.

Sponsored by National Heart, Lung, and Blood Institute (NHLBI) · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Cigarette smoking is the most common risk factor for lung cancer, and it increases the risk of developing other cancers, chronic lung disease, and heart disease. A smoking cessation program that incorporates physical activity may be beneficial in improving long-term smoking cessation rates. This study will evaluate the effectiveness of a community-based physical activity program, in combination with nicotine replacement therapy and a behavioral smoking cessation program, at improving cessation rates among sedentary smokers.

Read the detailed description

Tobacco use is the single most preventable cause of death in the United States, with cigarette smoking accounting for nearly one-third of all cancer deaths each year. While a number of inexpensive and effective smoking cessation methods exist, including the nicotine patch and nicotine gum, smoking rates have not declined in the past few years. Individuals who engage in regular exercise, in addition to participating in a smoking cessation program, are often successful at quitting smoking and reducing post-cessation weight gain. However, past studies on this topic have consisted of highly structured, supervised physical activity, which made study recruitment and long-term adherence difficult. Additionally, these studies generally have had low long-term quit rates, which may be attributed to the lack of a nicotine replacement component. The purpose of this study is to evaluate the effectiveness of a community-based physical activity intervention, in combination with a behavioral smoking cessation program and nicotine replacement, at increasing smoking cessation rates among sedentary adult smokers.

This 7-week study will enroll sedentary or minimally active cigarette smokers. All participants will take part in a behavioral smoking cessation program and will wear a nicotine patch. In addition, they will be randomly assigned to take part in either a community-based physical activity intervention or a wellness control group intervention. All participants will attend sixteen 60- to 90-minute face-to-face counseling sessions and twelve 20-minute telephone counseling sessions. They will also receive twelve informational mailings. Participants in the physical activity intervention will focus on increasing physical activity; the general wellness control group will receive information on general health topics. Outcome measures, including smoking status, physical activity levels, and body mass index, will be assessed at the end of the intervention and at 6- and 12-month follow-up visits.

02

Conditions studied

  • Smoking Cessation

Keywords

  • Physical Activity
  • Wellness Programs
  • Pharmacological Smoking Cessation
03

In context

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI) is the lead sponsor of 1,117 studies on the registry; 71 are open to participants now.

Of its 57 completed or terminated interventional studies of FDA-regulated products, 49 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Smokes five or more cigarettes each day in the year prior to study entry
  • Sedentary or minimally active physical activity level
  • Willing to be randomly assigned to either intervention group
  • Willing to use the nicotine patch

Exclusion criteria

Exclusion Criteria:

  • Pregnant, breastfeeding, or planning to become pregnant in the year following study entry
  • Planning to move out of the area in the year following study entry
  • Blood pressure greater than 160/95 mm Hg
  • Body weight greater than 140% of ideal body weight
  • History of heart attack, stroke, unstable angina, coronary artery bypass grafting, angioplasty, or stent in the 6 months prior to study entry
  • Symptomatic peripheral artery disease
  • History of congestive heart failure (New York Heart Association [NYHA] Class III or IV)
  • Electrocardiogram (EKG) evidence of 2nd or 3rd degree atrioventricular (AV) block
  • History of a serious illness that might limit longevity (e.g., significant kidney disease, liver disease, cancer)
  • Current substance abuse
  • Current alcohol use of more than 21 drinks per week
  • Uncontrolled arrhythmia or hyperthyroidism
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
400 participants (estimated)

Interventions

  • BehavioralSmoking Cessation Behavioral Program
  • DrugNicotine Patch
  • BehavioralPhysical Activity
06

What researchers measure

Primary outcomes

  1. Smoking status (measured immediately post-intervention and at 6- and 12-month follow-up visits)

Secondary outcomes

  1. Changes in self-reported and objective physical activity

  2. Body mass index

  3. Percentage of body fat

  4. Waist circumference (all measured immediately post-intervention and at 6- and 12-month follow-up visits)

07

Study locations

2 sites
  • University of Memphis Center for Community Health
    Memphis, Tennessee 38152, United States
  • Department of Preventive Medicine, University of Tennessee Health Science Center
    Memphis, Tennessee, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00403312
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
First posted
Nov 23, 2006
Start date
Jan 2003
Last update
Jul 2, 2008

Study contacts

Kenneth D. Ward, PhD
principal investigator · University of Memphis
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion